Sravani Edula

Manager -New Drug Development at ISSAR PHARMACEUTICALS - Hyderabad, Telangana, India

Sravani Edula's Contact Details
HQ
Location
Hyderabad,Telangana,India
Company
ISSAR PHARMACEUTICALS
Sravani Edula's Company Details
ISSAR PHARMACEUTICALS logo, ISSAR PHARMACEUTICALS contact details

ISSAR PHARMACEUTICALS

Hyderabad, Telangana, India • 13 Employees
Pharmaceuticals

Since its inception, Issar Pharma has been working on development of new peptide based drugs to treat different health problems. After six years of committed research, Issar Pharma invented and commercialised India's first ever indigenously developed new peptide molecule, Decapeptide, for the novel treatment of Vitiligo. This product was released into the market in 2004 under the product name Melgain®. Issar Pharma also invented and developed for the first time in the world its second peptide New Chemical Entity (NCE) which is first ever peptide based drug to treat burn wounds and microbial infection in India and world. This is going to be launched in Indian Market soon with the brand name of Xylentra™. The other molecules in pipeline are intended to be active against cancer, diabetic ulcers, HIV-AIDS, Acne, Psoriasis, Atopic Dermatitis, Inflammatory Bowel Disease, etc.

Details about ISSAR PHARMACEUTICALS
Frequently Asked Questions about Sravani Edula
Sravani Edula currently works for ISSAR PHARMACEUTICALS.
Sravani Edula's role at ISSAR PHARMACEUTICALS is Manager -New Drug Development.
Sravani Edula's email address is ***@. To view Sravani Edula's full email address, please signup to ConnectPlex.
Sravani Edula works in the Pharmaceuticals industry.
Sravani Edula's colleagues at ISSAR PHARMACEUTICALS are Padma Nagelli, Madhu Sudan, Venkataram Putcha, Vijay Kumar, Shiva Shivaprasadreddy, Bsrihari Srihari and others.
Sravani Edula's phone number is
See more information about Sravani Edula